Home Latest IAOO News >>> Join IAOO Constitution Memorandum and Articles Founding Fellows Fellows MembersFuture CongressesPast CongressesRelated MeetingsICOHNCAOfficial Journal Oral cancer linksMajor SponsorsContact IAOO

Arlene A. Forastiere MD

Professor of Oncology, The Johns Hopkins University School of Medicine

Professor of Otolaryngology, Head and Neck Surgery, and Radiation Oncology The Johns Hopkins University School of Medicine, Baltimore, Maryland USA

Arlene A. Forastiere, MD is an internationally recognized expert in head and neck oncology. Dr. Forastiere has made major contributions to the development of combined modality therapy and establishing standards of care for management of advanced head and neck. These include the integration of platinum-based chemotherapy and radiotherapy for organ preservation, post-operative management of high-risk head and neck cancer, the development of taxanes in head and neck cancer and most recently investigating agents that target the epidermal growth factor receptor signaling pathway. Dr. Forastiere is Professor of Oncology, and Otolaryngology, Head and Neck Surgery, and Radiation Oncology at the Johns Hopkins University School of Medicine. She is a graduate of New York Medical College (1975) and completed a Research Fellowship in Hematology-Oncology at Memorial Sloan-Kettering Cancer Center in 1980. She was Senior Investigator at the National Cancer Institute-Baltimore Cancer Research Program and on the faculty of the University of Maryland School of Medicine from 1980-1982. Dr. Forastiere was then appointed to the faculty of University of Michigan Medical School and was Director of Hematology-Oncology at the Ann Arbor Veterans Administration Medical Center from 1982-1988. She has been on the faculty of the Johns Hopkins School of Medicine since 1988. Dr. Forastiere is the Co-Principal Investigator of the NCI Specialized Program of Research Excellence (SPORE) in Head and Neck Cancer at Johns Hopkins. She is the Principal Investigator of the Eastern Cooperative Oncology Group (ECOG) Institutional Grant (1993-Present) and Director of the ECOG Clinical Trials Research Office (1993-Present). She is the Chair of the Head and Neck Committee for ECOG and formerly co-chaired the Head and Neck Committee of the Radiation Therapy Oncology Group. Dr. Forastiere is Chairman of the National Comprehensive Cancer Network (NCCN) Head and Neck Cancer Guidelines Panel. Dr. Forastiere served on the Board of Directors of the American Society of Clinical Oncology. She was Chair of the Education Committee and was Chair of the Committee on Public Issues and Government Relations. She is an Associate Editor for the Journal of Clinical Oncology. Dr. Forastiere has authored or co-authored more than 150 articles and 50 book chapters.

Arlene A. Forastiere MD

 

   

Last updated: 12/04/2005